Tag archive for ‘Global Market’
Gil Tanenbaum On Monday, November 3rd, 2014

Pharmaceutical NeuroDerm Prepares for NASDAQ IPO

NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...

Gil Tanenbaum On Sunday, September 21st, 2014

Foamix Disappointing IPO Drops Share Price to $6

Israeli biomedical firm Foamix is moving ahead with its New York IPO, but has greatly reduced its expectations, dropping it’s per share asking price to only $6 from the previously expected $10 to $12 range. The More...

Wordpress site Developed by Fixing WordPress Problems